182 related articles for article (PubMed ID: 19711976)
1. Movements of HIV-virions in human cervical mucus.
Boukari H; Brichacek B; Stratton P; Mahoney SF; Lifson JD; Margolis L; Nossal R
Biomacromolecules; 2009 Sep; 10(9):2482-8. PubMed ID: 19711976
[TBL] [Abstract][Full Text] [Related]
2. Imaging and tracking HIV viruses in human cervical mucus.
Boukari F; Makrogiannis S; Nossal R; Boukari H
J Biomed Opt; 2016 Sep; 21(9):96001. PubMed ID: 27598560
[TBL] [Abstract][Full Text] [Related]
3. Antibody-Mediated Immobilization of Virions in Mucus.
Jensen MA; Wang YY; Lai SK; Forest MG; McKinley SA
Bull Math Biol; 2019 Oct; 81(10):4069-4099. PubMed ID: 31468263
[TBL] [Abstract][Full Text] [Related]
4. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.
Shukair SA; Allen SA; Cianci GC; Stieh DJ; Anderson MR; Baig SM; Gioia CJ; Spongberg EJ; Kauffman SM; McRaven MD; Lakougna HY; Hammond C; Kiser PF; Hope TJ
Mucosal Immunol; 2013 Mar; 6(2):427-34. PubMed ID: 22990624
[TBL] [Abstract][Full Text] [Related]
5. Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.
Erickson AM; Henry BI; Murray JM; Klasse PJ; Angstmann CN
Biophys J; 2015 Jul; 109(1):164-72. PubMed ID: 26153713
[TBL] [Abstract][Full Text] [Related]
6. Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.
Bouchemal K; Aka-Any-Grah A; Dereuddre-Bosquet N; Martin L; Lievin-Le-Moal V; Le Grand R; Nicolas V; Gibellini D; Lembo D; Poüs C; Koffi A; Ponchel G
Antimicrob Agents Chemother; 2015 Apr; 59(4):2215-22. PubMed ID: 25645853
[TBL] [Abstract][Full Text] [Related]
7. Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Chen A; McKinley SA; Shi F; Wang S; Mucha PJ; Harit D; Forest MG; Lai SK
PLoS One; 2015; 10(7):e0131351. PubMed ID: 26132216
[TBL] [Abstract][Full Text] [Related]
8. HIV binding, penetration, and primary infection in human cervicovaginal tissue.
Maher D; Wu X; Schacker T; Horbul J; Southern P
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11504-9. PubMed ID: 16061810
[TBL] [Abstract][Full Text] [Related]
9. Diffusion of macromolecules and virus-like particles in human cervical mucus.
Olmsted SS; Padgett JL; Yudin AI; Whaley KJ; Moench TR; Cone RA
Biophys J; 2001 Oct; 81(4):1930-7. PubMed ID: 11566767
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
[TBL] [Abstract][Full Text] [Related]
11. Antibody diffusion in human cervical mucus.
Saltzman WM; Radomsky ML; Whaley KJ; Cone RA
Biophys J; 1994 Feb; 66(2 Pt 1):508-15. PubMed ID: 8161703
[TBL] [Abstract][Full Text] [Related]
12. Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus.
Mohamed AS; Becquart P; Hocini H; Métais P; Kazatchkine M; Bélec L
Clin Diagn Lab Immunol; 1997 Sep; 4(5):624-6. PubMed ID: 9302218
[TBL] [Abstract][Full Text] [Related]
13. In vitro models of mucosal HIV transmission.
Shattock RJ; Griffin GE; Gorodeski GI
Nat Med; 2000 Jun; 6(6):607-8. PubMed ID: 10835650
[No Abstract] [Full Text] [Related]
14. Encapsulating Quantum Dots within HIV-1 Virions through Site-Specific Decoration of the Matrix Protein Enables Single Virus Tracking in Live Primary Macrophages.
Li Q; Yin W; Li W; Zhang Z; Zhang X; Zhang XE; Cui Z
Nano Lett; 2018 Dec; 18(12):7457-7468. PubMed ID: 30398057
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal dynamics of HIV propagation.
Strain MC; Richman DD; Wong JK; Levine H
J Theor Biol; 2002 Sep; 218(1):85-96. PubMed ID: 12297072
[TBL] [Abstract][Full Text] [Related]
16. ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.
Gurer C; Höglund A; Höglund S; Luban J
J Virol; 2005 May; 79(9):5557-67. PubMed ID: 15827170
[TBL] [Abstract][Full Text] [Related]
17. How do cell-free HIV virions avoid infecting dead-end host cells and cell fragments?
Lyengar S; Schwartz DH
AIDS Rev; 2004; 6(3):155-60. PubMed ID: 15595432
[TBL] [Abstract][Full Text] [Related]
18. Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion.
Dale BM; McNerney GP; Thompson DL; Hubner W; de Los Reyes K; Chuang FY; Huser T; Chen BK
Cell Host Microbe; 2011 Dec; 10(6):551-62. PubMed ID: 22177560
[TBL] [Abstract][Full Text] [Related]
19. Origins of HIV-infected leukocytes and virions in semen.
Houzet L; Matusali G; Dejucq-Rainsford N
J Infect Dis; 2014 Dec; 210 Suppl 3():S622-30. PubMed ID: 25414416
[TBL] [Abstract][Full Text] [Related]
20. Meaningful interpretation of subdiffusive measurements in living cells (crowded environment) by fluorescence fluctuation microscopy.
Baumann G; Place RF; Földes-Papp Z
Curr Pharm Biotechnol; 2010 Aug; 11(5):527-43. PubMed ID: 20553227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
